Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725073 | SCV000333783 | uncertain significance | not provided | 2017-09-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725073 | SCV000535255 | likely benign | not provided | 2020-04-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000725073 | SCV001039830 | benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004678659 | SCV005179912 | likely benign | Inborn genetic diseases | 2024-04-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004547667 | SCV004764309 | likely benign | WDR62-related disorder | 2019-11-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |